Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  Tiprolisant oxalate

Tiprolisant oxalate

Basic information Safety Supplier Related

Tiprolisant oxalate Basic information

Product Name:
Tiprolisant oxalate
Synonyms:
  • Pitolisant (oxalate)
  • Tiprolisant oxalate
  • 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]piperidine ethanedioate (1:1)
  • Pitolisant ethanedioate (1:1)
CAS:
362665-57-4
MF:
C19H28ClNO5
MW:
385.88232
Mol File:
362665-57-4.mol
More
Less

Tiprolisant oxalate Chemical Properties

storage temp. 
Store at -20°C
solubility 
DMSO : 50 mg/mL (129.57 mM; Need ultrasonic)
form 
Powder
color 
Off-white to light yellow
More
Less

Tiprolisant oxalate Usage And Synthesis

Uses

Pitolisant oxalate is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).

in vivo

The administration of Pitolisantat a single dose of 10 mg/kg 30 min before a single dose of Olanzapine (2 mg/kg b.w.) also significantly affects immobility time in the FST. Subsequent administration of the aforementioned drug sequence in mice statistically significantly increases the duration of immobility in comparison to the time determined in the control group in the FST. It decreased locomotor activity as well. In contrast, the results obtained in subchronic treatment after fifteen administrations of both drugs (Pitolisant 10 mg/kg b.w., and after 30 min Olanzapine 2 mg/kg b.w., and again after 4 h Olanzapine 2 mg/kg b.w.) show that the administration of Pitolisant followed by that of Olanzapine equalized the locomotor activity in mice; in comparison to the level of motility in the control group, to which only Pitolisant is administered. More importantly, this combination of drugs significantly reduces immobility time to the level obtained in the control group in the forced swim test in mice [one-way ANOVA; F (3,20)=4.226,P=0.0181][2]. Rats given Pitolisant (10 mg/kg) during the conditioning phase stayed 502±94 s on the paired texture, a value not statistically different from that of controls, indicating that Pitolisant did not support place preference[3].

References

[1] Ligneau X, et al. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J Pharmacol Exp Ther. 2007 Jan;320(1):365-75. DOI:10.1124/jpet.106.111039
[2] Dudek M, et al. H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice. Metab Brain Dis. 2016 Oct;31(5):1023-9. DOI:10.1007/s11011-016-9840-z
[3] Uguen M, et al. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H? receptor inverse agonist/antagonist compared with Modafinil. Br J Pharmacol. 2013 Jun;169(3):632-44. DOI:10.1111/bph.12149

Tiprolisant oxalateSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
Deyang Yuehe Bio-Pharmaceutical Co.,Ltd
Tel
028-82729560 18030702676
Email
sales@yuehepharm.com
SPIRO PHARMA
Tel
Email
eric_feng1954@126.com
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com